In this study, we identified dysregulated expression of the metabolic enzyme MTAP in aggressive RCC and demonstrated that MTAP-mediated RCC suppression occurs because of inhibited IGF1R signaling. The gene discussed is MTAP; the disease is renal cell carcinoma.